Pfizer

There might finally be a Lyme disease vaccination next year – but now it all comes down to whether there was enough disease in the study population despite the drug's solid efficacy across those infected

World's first vaccine for Lyme disease could be available in 2027

Scientists are confident they've got the first effective Lyme disease vaccine, but the final hurdle will be FDA approval – which the drug-makers are seeking despite unexpected statistical issues. It remains to be seen if this will derail their goals.

Pfizer pulls ahead in the race to develop an mRNA influenza vaccine – but some questions remain

Illnesses and conditions

mRNA flu shot far more effective than current vaccine – but there are issues

In a Phase 3 trial of more than 18,000 volunteers across three countries, a novel mRNA influenza vaccine developed by Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this biotechnology is here to stay.

This time next year, you may be swapping GLP-1 injections for oral medication i

Obesity

Breakthrough weight-loss pill expected to launch within 12 months

The first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again.